1. Access to essential medicines of the future Bernard Pécoul Director, Campaign for Access to Essential Medicines Médecins Sans Frontières

2. A sleeping sickness patient, N'dalatando, Angola, 1997

3. Justice Access to essential medicines as a human right Essential medicines as public goods

4. Justice

6. The right of access to essential medicines

8. Essential medicines as public goods

9. Some essential medicines still not on the List Overcome intellectual property barriers to access Address R&D crisis for medicines for developing country diseases Maintain the production of essential medicines and secure the market Future challenges for essential medicines

10. Some essential medicines still not included on the List

11. Overcome intellectual property barriers to access

12. The Effects of Generic Competition Stavudine (d4T) + lamivudine (3TC) + nevirapine (NVP): Lowest world prices per patient per year

13. Address R&D crisis for medicines for developing country diseases

14. Research for drugs for neglected diseases 1975 to 1999: 1,393 new chemical entities marketed Tropical diseases: 13 Tuberculosis: 3

15. Maintain the production of essential medicines and secure the market